Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BioSig Technologies Inc BSGM

Healthcare Medical Devices
BioSig Technologies, Inc. is a medical technology company focused on deciphering the body’s electrical signals, starting with heart rhythms. The Company’s product, the PURE EP Platform, a non-invasive class II device, provides real-time signal visualization allowing physicians to perform highly targeted cardiac ablation procedures. Integrating with existing systems in the EP lab, PURE EP is designed to pinpoint even the complex signals to maximize procedural success and efficiency. The PURE EP System is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures, such as environmental lab noise from other equipment, signal saturation, slow signal recovery, and inaccurate display of fractionated potentials. PURE EP is a signal processing platform that combines advanced hardware and software to address known challenges associated to signal acquisition, to enable electrophysiologists to see more signals and analyze them in real-time.


NDAQ:BSGM - Post by User

BioSig Technologies Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(2)
•••
Post by Adwarion Nov 02, 2021 1:51pm
172 Views
Post# 34078300

Seeking Alpha Poured Cold Water on it

Seeking Alpha Poured Cold Water on it

BioSig makes record gains after exceeding procedural target for 2021

BioSig Technologies (BSGM +19.6%) has climbed to post the biggest intraday gain since April 2020 after the company announced that it has already surpassed the procedural target of 1500 patient cases set for 2021.

By Oct. 21, over 71 physicians had used the company’s PURE EP(tm) System in 1,560 patient cases, up from 1,000 cases in June 2021 when the procedural guidance was raised to reflect the rising usage in elective procedures.

By the end of 2021, the company expects to complete 1,700-1,800 procedures as the adoption of the technology rises amid falling COVID-19 hospitalizations.

“We are seeing increased utilization of PURE EP(tm) in the 13 hospitals we are currently working in,” CEO Kenneth L. Londoner, remarked.

According to latest financials, BioSig (NASDAQ:BSGM) has failed meet the consensus revenue estimates for two consecutive quarters.

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities